Developmental and Genetic Regulation of Human Surfactant Protein B in vivo

Background: Genetic and developmental disruption of surfactant protein B (SP-B) expression causes neonatal respiratory distress syndrome (RDS). Objectives: To assess developmental and genetic regulation of SP-B expression in vivo. Methods: To evaluate in vivo developmental regulation of SP-B, we use...

Full description

Saved in:
Bibliographic Details
Published inNeonatology (Basel, Switzerland) Vol. 95; no. 2; pp. 117 - 124
Main Authors Hamvas, Aaron, Heins, Hillary B., Guttentag, Susan H., Wegner, Daniel J., Trusgnich, Michelle A., Bennet, Kate W., Yang, Ping, Carlson, Christopher S., An, Ping, Cole, F. Sessions
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.02.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Genetic and developmental disruption of surfactant protein B (SP-B) expression causes neonatal respiratory distress syndrome (RDS). Objectives: To assess developmental and genetic regulation of SP-B expression in vivo. Methods: To evaluate in vivo developmental regulation of SP-B, we used immunoblotting to compare frequency of detection of mature and pro-SP-B peptides in developmentally distinct cohorts: 24 amniotic fluid samples, unfractionated tracheal aspirates from 101 infants ≥34 weeks’ gestation with (75) and without (26) neonatal RDS, and 6 nonsmoking adults. To examine genetic regulation, we used univariate and logistic regression analyses to detect associations between common SP-B (SFTPB) genotypes and SP-B peptides in the neonatal RDS cohort. Results: We found pro-SP-B peptides in 24/24 amniotic fluid samples and in 100/101 tracheal aspirates from newborn infants but none in bronchoalveolar lavage from normal adults (0/6) (p < 0.001). We detected an association (p = 0.0011) between pro-SP-B peptides (M r 40 and 42 kDa) and genotype of a nonsynonymous single nucleotide polymorphism at genomic position 1580 that regulates amino-terminus glycosylation. Conclusions: Pro-SP-B peptides are more common in developmentally less mature humans. Association of genotype at genomic position 1580 with pro-SP-B peptides (M r 40 and 42 kDa) suggests genetic regulation of amino terminus glycosylation in vivo.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These data were presented at the Pediatric Academic Societies’ Meetings in San Francisco, May 2004 and 2006, and in Washington, D.C., May 2005 (E-PAS 2006:59:2610.4; Pediatr Res 2005;57:2502, and Pediatr Res 2004;55:2664).
ISSN:1661-7800
1661-7819
DOI:10.1159/000153095